These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 28420549)

  • 21. Impacts of non-recovery of trastuzumab-induced cardiomyopathy on clinical outcomes in patients with breast cancer.
    Yoon HJ; Kim KH; Kim HY; Park H; Cho JY; Hong YJ; Park HW; Kim JH; Ahn Y; Jeong MH; Cho JG; Park JC
    Clin Res Cardiol; 2019 Aug; 108(8):892-900. PubMed ID: 30737527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrence of left ventricular dysfunction in patients with restored idiopathic dilated cardiomyopathy.
    Park JS; Kim JW; Seo KW; Choi BJ; Choi SY; Yoon MH; Hwang GS; Tahk SJ; Shin JH
    Clin Cardiol; 2014 Apr; 37(4):222-6. PubMed ID: 24452755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of myocardial blood flow reserve in idiopathic dilated cardiomyopathy without overt heart failure and its relation with functional indices: an echo-Doppler and positron emission tomography study.
    Morales MA; Neglia D; L'Abbate A
    J Cardiovasc Med (Hagerstown); 2008 Aug; 9(8):778-82. PubMed ID: 18607240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left Ventricular Torsion　- A New Echocardiographic Prognosticator in Patients With Non-Ischemic Dilated Cardiomyopathy.
    Rady M; Ulbrich S; Heidrich F; Jellinghaus S; Ibrahim K; Linke A; Sveric KM
    Circ J; 2019 Feb; 83(3):595-603. PubMed ID: 30662022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between Myocardial Extracellular Space Expansion Estimated with Post-Contrast T1 Mapping MRI and Left Ventricular Remodeling and Neurohormonal Activation in Patients with Dilated Cardiomyopathy.
    Yoon JH; Son JW; Chung H; Park CH; Kim YJ; Chang HJ; Hong GR; Kim TH; Ha JW; Choi BW; Rim SJ; Chung N; Choi EY
    Korean J Radiol; 2015; 16(5):1153-62. PubMed ID: 26355278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tenascin-C as predictor of left ventricular remodeling and mortality in patients with dilated cardiomyopathy.
    Sarli B; Topsakal R; Kaya EG; Akpek M; Lam YY; Kaya MG
    J Investig Med; 2013 Apr; 61(4):728-32. PubMed ID: 23429699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and prognostic relevancy of left ventricular trabeculation assessed by cardiac magnetic resonance in patients with dilated cardiomyopathy.
    Mazurkiewicz Ł; Petryka J; Śpiewak M; Miłosz-Wieczorek B; Małek ŁA; Jasińska A; Jarmus E; Marczak M; Misko J; Grzybowski J
    Kardiol Pol; 2017; 75(8):794-803. PubMed ID: 28541593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of disease progression in pediatric dilated cardiomyopathy.
    Molina KM; Shrader P; Colan SD; Mital S; Margossian R; Sleeper LA; Shirali G; Barker P; Canter CE; Altmann K; Radojewski E; Tierney ES; Rychik J; Tani LY;
    Circ Heart Fail; 2013 Nov; 6(6):1214-22. PubMed ID: 24132734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of left atrial enlargement in patients with idiopathic dilated cardiomyopathy and ischemic cardiomyopathy.
    Dini FL; Cortigiani L; Baldini U; Boni A; Nuti R; Barsotti L; Micheli G
    Am J Cardiol; 2002 Mar; 89(5):518-23. PubMed ID: 11867034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart failure biomarkers in patients with dilated cardiomyopathy.
    Bielecka-Dabrowa A; von Haehling S; Aronow WS; Ahmed MI; Rysz J; Banach M
    Int J Cardiol; 2013 Oct; 168(3):2404-10. PubMed ID: 23416015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome and prognostic value of N-terminal pro-brain natriuretic peptide and high-sensitivity C-reactive protein in mildly dilated cardiomyopathy vs. dilated cardiomyopathy.
    Feng J; Tian P; Liang L; Chen Y; Wang Y; Zhai M; Huang Y; Zhou Q; Zhao X; Zhao L; Huang B; Huang L; Zhang Y; Zhang J
    ESC Heart Fail; 2022 Jun; 9(3):1625-1635. PubMed ID: 35243815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic utility of anemia and pro-B-type natriuretic peptide in patients with nonischemic dilated cardiomyopathy and normal renal function.
    Tigen K; Karaahmet T; Cevik C; Gurel E; Mutlu B; Basaran Y
    Am J Med Sci; 2009 Feb; 337(2):109-15. PubMed ID: 19214026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiation between athlete's heart and dilated cardiomyopathy in athletic individuals.
    Millar LM; Fanton Z; Finocchiaro G; Sanchez-Fernandez G; Dhutia H; Malhotra A; Merghani A; Papadakis M; Behr ER; Bunce N; Oxborough D; Reed M; O'Driscoll J; Tome Esteban MT; D'Silva A; Carr-White G; Webb J; Sharma R; Sharma S
    Heart; 2020 Jul; 106(14):1059-1065. PubMed ID: 32341137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Impact of Hypertrabeculation and Noncompaction Phenotype in Dilated Cardiomyopathy: A CMR Study.
    Amzulescu MS; Rousseau MF; Ahn SA; Boileau L; de Meester de Ravenstein C; Vancraeynest D; Pasquet A; Vanoverschelde JL; Pouleur AC; Gerber BL
    JACC Cardiovasc Imaging; 2015 Aug; 8(8):934-46. PubMed ID: 26189121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left Atrial Volume as a Predictor of Left Ventricular Functional Recovery in Patients With Dilated Cardiomyopathy and Absence of Delayed Enhancement in Cardiac Magnetic Resonance.
    Moon J; Shim CY; Kim YJ; Park S; Kang SM; Chung N; Ha JW
    J Card Fail; 2016 Apr; 22(4):265-71. PubMed ID: 26700660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.
    Kosztin A; Kutyifa V; Nagy VK; Geller L; Zima E; Molnar L; Szilagyi S; Ozcan EE; Szeplaki G; Merkely B
    Europace; 2016 Apr; 18(4):550-9. PubMed ID: 26116830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hazards of ventricular pre-excitation to left ventricular systolic function and ventricular wall motion in children: analysis of 25 cases.
    Guo B; Dai C; Li Q; Li W; Han L
    Cardiol Young; 2019 Mar; 29(3):380-388. PubMed ID: 30767835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Clinical Course and Outcomes between Dilated and Hypokinetic Non-Dilated Cardiomyopathy.
    Dziewięcka E; Winiarczyk M; Wiśniowska-Śmiałek S; Karabinowska-Małocha A; Robak J; Kaciczak M; Baranowski F; Rubiś P
    Cardiology; 2023; 148(5):395-401. PubMed ID: 37311443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Posterior restoration procedures and the long-term results in indicated patients with dilated cardiomyopathy †.
    Isomura T; Hirota M; Notomi Y; Hoshino J; Kondo T; Takahashi Y; Yoshida M
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):725-31; discussion 731. PubMed ID: 25736271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical implications of serial serum N-terminal prohormone brain natriuretic peptide levels in the prediction of outcome in children with dilated cardiomyopathy.
    Kim G; Lee OJ; Kang IS; Song J; Huh J
    Am J Cardiol; 2013 Nov; 112(9):1455-60. PubMed ID: 24035042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.